Depression

This evidence summary provides an overview of the current evidence for secondary school-based mental health prevention programs.

This resource will provide a review of the latest evidence for antidepressant medication, primarily selective serotonin-reuptake inhibitors (SSRIs) and selective noradrenaline reuptake inhibitors (SNRIs), in the treatment of depressive disorders in young people. For the purpose of this document the term ‘young people’ refers to individuals aged 12–25, unless otherwise specified.